Baker IDI Heart and Diabetes Institute

But this was not the case for those with dyslipidemic levels that resolved by adulthood

Is BP screening starting before age 3 years warranted?

Baker Heart and Diabetes Institute researchers have designed and developed a novel drug delivery method that can vastly improve the efficacy of a drug used to treat atherosclerosis and has the potential to identify and treat other diseases.

Even for 60ish youngsters, researchers reaffirm that exercise is essential. But just walking won't cut it — break out the weights and go for strength training too.

It doesn't take a doctor to catch congestion

Persons who work remotely are at increased risk for low back pain because of poor ergonomics and extended time spent sitting.

But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy

A fluttering heartbeat called A-fib can lead to stroke, but smartwatches can detect it, and there are good treatments

The trial argues against a common ablation add-on to standard pulmonary vein isolation in patients undergoing a first catheter ablation for persistent AF.

The trial missed its primary endpoint at 12 months but showed clinically meaningful benefits on VO2 peak and cardiac reserve not captured by standard measures.

A new study found that various types of coffee -- decaffeinated, ground and instant -- could all protect you from heart disease and an early death.

DOCTORS in Australia are developing the country's first SADS registry after an increase in healthy young people dying from Sudden Adult Death Syndrome.

Elite athletes who suffer a sudden cardiac arrest might have genetics that make them more vulnerable to heart disease, a new study suggests.

Effectiveness, safety similar between sexes in Europe's early Farapulse experience

Diabetes researchers say they have made a breakthrough that could pave the way to eliminating the need for daily insulin injections.

Media outlets around the world have started highlighting a medical phenomenon called 'sudden adult death syndrome' - people ...

At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed-loop automated insulin delivery system.

CAUGHT-CAD trial adds credence to a CAC-informed primary prevention strategy

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based cohort study found.

Cell membranes from comb jellies reveal a new kind of adaptation to the deep sea: curvy lipids that conform to an ideal shape under pressure.